MDXG News Alert Mimedx Group Inc (MDXG) 11.17 12/25/2014 13:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mimedx Group Inc (MDXG) 11.17 $MDXG

MiMedx To Present At 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Mon Dec 22, 1:28PM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced the schedule for its presentation at the 33rd Annual J. P. Morgan Healthcare Conference. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, will present on Thursday, January 15, 2015, 9:00 a.m. PST, at the Westin St. Francis Hotel in San Francisco. A webcast of this presentation will be available on the Company's website, www.mimedx.com.
JPM: 62.48 (unch), MDXG: 11.17 (+0.17)

MiMedx updates 2015 guidance
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:52AM CST

MDXG: 11.17 (+0.17)

United States Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry Analytics 2014-2021 - Market to reach $39.5 billion by 2021
M2 - Mon Dec 15, 8:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/s847lc/vaccines_skin) has announced the addition of Plunkett Research Ltd's new report "Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked - Anika Therapeutics Inc - CSL Behring LLC - Emergent BioSolutions Inc - Halozyme Therapeutics Inc - LifeCell Corporation - Lifecore Biomedical Inc - MiMedx Group Inc - Organogenesis Inc - RTI Biologics Inc - Zoetis Inc For more information visit http://www.researchandmarkets.com/research/s8...cines_skin Source: Plunkett Research Ltd
ZTS: 43.84 (+0.87), RTIX: 5.20 (unch), HALO: 9.34 (+0.31), EBS: 27.64 (+1.28), ANIK: 38.26 (+0.73), MDXG: 11.17 (+0.17)

MiMedx Raises Expectations For 2015 Revenue To Range From $175 Million To $190 Million
PR Newswire - Mon Dec 15, 7:45AM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its updated outlook for 2015.
MDXG: 11.17 (+0.17)

MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day
PR Newswire - Fri Dec 12, 8:30AM CST
Zacks Equity Research highlights MiMedx Group, Inc. (Nasdaq:MDXG-Free Report) as the Bull of the Day and Conn's (Nasdaq:CONN-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Mylan Inc. (Nasdaq:MYL-Free Report), Pfizer (NYSE FE-Free Report) and Amgen Inc. (Nasdaq:AMGN-Free Report).
AMGN: 160.67 (+3.15), MDXG: 11.17 (+0.17)

Zacks' Bull Of The Day: MiMedx
Zacks Investment Research - Seeking Alpha - Fri Dec 12, 5:53AM CST
Today's Bull of the Day comes from biomedical/genetics industry that currently ranks in the Top 22% of our Zacks Industry Rank. If you're looking for innovation and trying to find a company with great revenue growth poised to stick around for the...
MDXG: 11.17 (+0.17)

Bull of the Day: MiMedx (MDXG) - Bull of the Day
David Bartosiak - ZACKS - Fri Dec 12, 12:00AM CST
Bull of the Day: MiMedx (MDXG) - Bull of the Day
MDXG: 11.17 (+0.17)

MiMedx To Present At The Oppenheimer 25th Annual Healthcare Conference
PR Newswire - Thu Dec 04, 8:00AM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it will present at the Oppenheimer 25th Annual Healthcare Conference in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on Wednesday, December 10th, 11:30 a.m. EST, at the Crowne Plaza Hotel. A webcast of this presentation will be available on the Company's website, www.mimedx.com.
MDXG: 11.17 (+0.17)

Can MiMedx Group (MDXG) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:39AM CST
MiMedx Group (MDXG) has decent short-term momentum and is seeing solid activity on the earnings estimate revision front. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on MDXG’s earnings for the coming quarter and year.
MDXG: 11.17 (+0.17)

Can MiMedx Group (MDXG) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 7:53AM CST
MiMedx Group has been witnessing a nice streak of beating earnings estimates. In fact, the company currently has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming beat.
MDXG: 11.17 (+0.17)

Thirteen Poster Abstracts Chronicling The Clinical Use, Cost Effectiveness And Accelerated Healing Results of MiMedx Products to be Presented by VA Physicians at Desert Foot Conference
PR Newswire - Tue Nov 18, 7:00AM CST
MiMedx Group, Inc. (NASDAQ: MDXG) announced today that fourteen poster abstracts chronicling the Company's dehydrated human amnion/chorion membrane (dHACM) allografts to be clinically effective and cost effective in the healing of chronic wounds, difficult lower extremity wounds that have failed prior wound treatment modalities, challenging surgical wounds, chronic neuropathic wounds, wounds threatening the loss of limbs, and other hard-to-heal wounds will be presented at the 11th Annual Desert Foot High Risk Diabetic Foot Conference in Phoenix, Arizona, beginning November 19, 2014, and concluding on November 21, 2014. The abstracts describe the results of independent case studies undertaken by the presenters.
MDXG: 11.17 (+0.17)

MiMedx's Competitive Advantage And Management Execution Charts Path To Future Growth And Shareholder Opportunity
Dave Kelly - at Seeking Alpha - Tue Nov 18, 5:45AM CST

ZMH: 114.11 (+0.64), MDT: 74.08 (+0.31), MDXG: 11.17 (+0.17)

Multi-Center Comparative Study Of MiMedx EpiFix® And Organogenesis Apligraf® Determines EpiFix Has Considerably Higher Rates Of Complete Healing And Significantly Faster Time To Heal
PR Newswire - Mon Nov 17, 3:01PM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that its latest peer-reviewed clinical study has been accepted for publication in the International Wound Journal.
MDXG: 11.17 (+0.17)

MiMedx elects Christopher M. Cashman as EVP
M2 - Mon Nov 10, 8:11AM CST
Regenerative medicine company MiMedx Group (NasdaqCM:MDXG) announced on Friday that it has appointed Christopher M. Cashman as its executive vice president & chief commercialisation officer.
MDXG: 11.17 (+0.17)

MiMedx® Adds New Executive
PR Newswire - Fri Nov 07, 8:39AM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that Christopher M. Cashman has joined MiMedx as the Company's Executive Vice President & Chief Commercialization Officer.
MDXG: 11.17 (+0.17)

Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx
PR Newswire - Fri Nov 07, 7:35AM CST
Investor-Edge has initiated coverage on the following equities: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), PDL BioPharma Inc. (NASDAQ: PDLI), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), OPKO Health Inc. (NYSE: OPK), and MiMedx Group Inc. (NASDAQ: MDXG). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, November 6, 2014, the NASDAQ Composite ended at 4,638.47, up 0.38%, the Dow Jones Industrial Average advanced 0.40%, to finish the day at 17,554.47, and the S&P 500 closed at 2,031.21, up 0.38%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 782.64, up 0.57%, with the index also advancing 11.74% in the previous three months. Register for your complimentary reports on these five stocks at:
SGYP: 3.08 (+0.12), OPK: 9.63 (+0.21), VNDA: 14.69 (+1.11), MDXG: 11.17 (+0.17), PDLI: 7.61 (unch)

MiMedx To Present At Two Healthcare Conferences
PR Newswire - Wed Nov 05, 1:59PM CST
MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it will present at two healthcare conferences in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present at the 2014 Stifel Healthcare Conference on Wednesday, November 19, 2014 at 11:30 am EST at the Palace Hotel. Management will also present at 8:00 am EST on Thursday, November 20, 2014, at the Canaccord|Genuity Forum, which is being held at the Westin Grand Central Hotel. Webcasts of each presentation will be available on the Company's website, www.mimedx.com.
MDXG: 11.17 (+0.17)

MiMedx raises full year 2014 guidance after Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 5:42AM CDT

MDXG: 11.17 (+0.17)

MiMedx Group's (MDXG) CEO Parker Petit on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:54PM CDT

MDXG: 11.17 (+0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 58

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Millrose Lawsuit Puts Disclosure Discipline in Focus

Updated Category News Views 64

A supposedly clean homesite-option story has wandered into the legal weeds, and that is exactly where investors need to slow down. A shareholder class action against Millrose Properties alleges the company painted one business model for the market while pursuing a materially different one behind the curtain. That allegation has not been proven in court, and anybody...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 103

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Korla Kiln Gains Show How Cement Efficiency Is Won

Updated Category News Views 93

A cement kiln does not care about corporate slogans; it cares whether the flame holds, the bearings stay alive, and the feed keeps moving. That is why the work at Xinjiang Tianshan Cement's Tashidian branch in Korla deserves a closer look. This is not a glossy tale about a futuristic factory appearing overnight. It is an account of an old, unforgiving industrial process...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 28

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 93

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 58

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading

Top 5 Most Recently Viewed Articles

AI/R Targets 2025 IPO Amidst Rapid AI Advancements

Updated Category News Views 488

AI/R Sets 2025 IPO Goals as AI Innovations Surge AI/R, a leading provider of artificial intelligence platforms and services, has exciting plans for a public offering in 2025. As a global player in the AI industry, renowned companies like Toyota, BP, and Nestlé benefit from AI/R's innovative solutions. The company anticipates impressive revenues exceeding $350 million for...

Continue Reading
Sable Implements New Equity Plan to Enhance Shareholder Value

Updated Category News Views 228

Sable Resources Ltd. Unveils Innovative Equity Incentive Plan VANCOUVER, British Columbia — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: SBLRF) has announced an exciting new chapter for the company with the recent approval of its Equity Incentive Plan at the annual shareholder meeting. The approval reflects strong support from...

Continue Reading
Unlock Savings This Black Friday with AKKO's Amazing Deals

Updated Category News Views 163

Get Ready for AKKO's Black Friday Extravaganza As the holiday season draws near, AKKO is set to surprise European users with spectacular Black Friday deals. During this promotional event, you can enjoy discounts of up to 50% on premium mechanical keyboards, keycaps, and various accessories. Whether you are a competitive gamer seeking high performance or an everyday user...

Continue Reading
Ping An Health Sets Benchmark with WONCA Certifications in Care

Updated Category News Views 156

Ping An Health Achieves Notable WONCA Certifications Recently, Ping An Healthcare Technology Co., Ltd. successfully obtained the prestigious Digital Health Certificate (DHC) and the Development & Enhancement Program (DEP) Certificate from the World Organization of Family Doctors (WONCA). This makes Ping An Health the first healthcare and eldercare service company in the...

Continue Reading
Gallatin AI's Navigator Solution Gains DoD Recognition

Updated Category News Views 277

Gallatin AI's Navigator Solution Gains 'Awardable' Status Gallatin AI, an innovative startup committed to evolving defense logistics, has announced significant news regarding its flagship product, Gallatin Navigator. This advanced logistics operating system has officially achieved 'Awardable' status under the Department of Defense's Tradewinds Solutions Marketplace. This...

Continue Reading